Host‐Microbial Interactions in Idiopathic Pulmonary Fibrosis
暂无分享,去创建一个
Athol U. Wells | Phillip James | Philip L. Molyneaux | Toby M. Maher | M. Moffatt | A. Wells | T. Maher | P. Molyneaux | C. Stock | E. Renzoni | M. Cox | W. Cookson | M. Loebinger | Miriam F. Moffatt | Michael J. Cox | S. Willis-Owen | Lindsay M. Edwards | A. Blanchard | Elisabetta A. Renzoni | Cécile Daccord | Michael Loebinger | William O. C. Cookson | Saffron A. G. Willis‐Owen | Steven Cowman | Andrew Blanchard | Carmel Stock | C. Daccord | S. Cowman | P. James
[1] A. Aceti,et al. α‐Defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection , 2006, Journal of viral hepatitis.
[2] Hao Xu,et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.
[3] Jong-Min Song,et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.
[4] S. Johnston,et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.
[5] Naping Li,et al. Bleomycin-induced nuclear factor-kappaB activation in human bronchial epithelial cells involves the phosphorylation of glycogen synthase kinase 3beta. , 2009, Toxicology letters.
[6] I. Noth,et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.
[7] M. Nakazato,et al. Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. , 2002, Thorax.
[8] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] Peter Langfelder,et al. Eigengene networks for studying the relationships between co-expression modules , 2007, BMC Systems Biology.
[10] G. Laurent,et al. Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis , 2016, Laboratory Investigation.
[11] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[12] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[13] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[14] Kevin J Anstrom,et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.
[15] Meilan K. Han,et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. , 2014, The Lancet. Respiratory medicine.
[16] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[17] Jin Woo Song,et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[18] Ivana V. Yang,et al. Muc5b is required for airway defence , 2013, Nature.
[19] Naftali Kaminski,et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.
[20] E. Chilvers,et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial , 2012, Thorax.
[21] T. Maher,et al. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis , 2013, European Respiratory Review.
[22] J. Farrar,et al. Human TOLLIP Regulates TLR2 and TLR4 Signaling and Its Polymorphisms Are Associated with Susceptibility to Tuberculosis , 2012, The Journal of Immunology.
[23] Murali M. Yallapu,et al. Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.
[24] A. Kulkarni,et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing , 2000, Nature Medicine.
[25] Daniel R. Salomon,et al. Strategies for aggregating gene expression data: The collapseRows R function , 2011, BMC Bioinformatics.
[26] C. Owen,et al. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. , 2015, American journal of respiratory cell and molecular biology.
[27] Elissa Murphy,et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.
[28] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[29] R. Hubbard,et al. The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.
[30] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[31] K. Fukase,et al. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. , 2005, Blood.
[32] I. Noth,et al. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.
[33] Ivana V. Yang,et al. Gene expression profiling of familial and sporadic interstitial pneumonia. , 2007, American journal of respiratory and critical care medicine.
[34] G. Laurent,et al. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? , 2007, European Respiratory Journal.
[35] Y. Wang,et al. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. , 2000, The Journal of pharmacology and experimental therapeutics.
[36] George C Tseng,et al. Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis , 2013, Science Translational Medicine.
[37] S. Horvath,et al. Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.